Journal of Adolescent Health
Volume 39, Issue 5 , Pages 642-648 , November 2006

Adolescent HIV Prevalence, Sexual Risk, and Willingness to Participate in HIV Vaccine Trials

  • Heather B. Jaspan, M.D., Ph.D.

      Affiliations

    • Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa
    • Corresponding Author InformationAddress correspondence to: Dr. Heather Jaspan, Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, University of Cape Town Faculty of Health Sciences, Anzio Road, Observatory 7925, Cape Town, South Africa.
    • ,
  • Jessica R. Berwick, B.S.

      Affiliations

    • Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa
    • ,
  • Landon Myer, Ph.D.

      Affiliations

    • School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa
    • ,
  • Catherine Mathews, Ph.D.

      Affiliations

    • School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa
    • Health Systems Research Unit, Medical Research Council, South Africa, Cape Town, South Africa
    • ,
  • Alan J. Flisher, M.B.Ch.B., Ph.D.

      Affiliations

    • Division of Child and Adolescent Psychiatry, University of Cape Town, Cape Town, South Africa
    • ,
  • Robin Wood, M.Med.

      Affiliations

    • Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa
    • ,
  • Linda-Gail Bekker, M.B.Ch.B., Ph.D.

      Affiliations

    • Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa

Received 13 February 2006 ,Accepted 19 May 2006.

References 

  1. Shisana O, Stoker D, Simbayi LC, et al. South African national household survey of HIV/AIDS prevalence, behavioural risks and mass media impact—detailed methodology and response rate results. S Afr Med J. 2004;94(4):283–288
  2. Department of Health, Republic of South Africa. National HIV and Syphilis Antenatal Sero-prevalence Survey in South Africa 2003. Pretoria, South Africa: Department of Health; 2004;
  3. Department of Health, Republic of South Africa. National HIV and Syphilis Antenatal Sero-prevalence Survey in South Africa 2004. Pretoria, South Africa: Department of Health; 2005;
  4. Pettifor AE, Rees HV, Kleinschmidt I, et al. Young people’s sexual health in South Africa: HIV prevalence and sexual behaviors from a nationally representative household survey. AIDS. 2005;19(14):1525–1534
  5. Eaton L, Flisher AJ, Aaro LE. Unsafe sexual behaviour in South African youth. Soc Sci Med. 2003;56(1):149–165
  6. Jaspan HB, Gray GE, Robinson AKL, et al. Scientific justification for the participation of children and adolescents in HIV-1 vaccine trials in South Africa. S Afr Med J. 2005;95(9):685–687
  7. Jaspan HB, Lawn SD, Safrit JT, et al. The maturing immune system: implications for development and testing HIV-1 vaccines for children and adolescents. AIDS. 2006;20:483–494
  8. Visser M, Moleko A. High-risk behaviour of primary school learners. Urban Health Dev Bull. 1999;2:69–77
  9. National Progressive Primary Health Care Network. Youth Speak Out for a Healthy Future: A Study of Youth Sexuality. Johannesburg, South Africa: National Progressive Primary Health Care Network; 1999;
  10. Mathews C, Kuhn L, Metcalf CC, et al. Knowledge, attitudes and beliefs about AIDS in township school students in Cape Town. S Afr Med J. 1990;78(90):511–516
  11. Newman PA, Duan N, Roberts KJ, et al. HIV vaccine trial participation among ethnic minority communities: barriers, motivators, and implications for recruitment. J Acquir Immune Defic Syndr. 2006;41:210–217
  12. de Souza CTV, Lowndes CM, Szwarcwald CL, et al. Willingness to participate in HIV vaccine trials among a sample of men who have sex with men, with and without a history of commercial sex, Rio de Janeiro, Brazil. AIDS Care. 2003;15:539–548
  13. Sahay S, Mehendale S, Sane S, et al. Correlates of HIV vaccine trial participation: an Indian perspective. Vaccine. 2005;23:1351–1358
  14. Zimet GD, Fortenberry JD, Blythe MJ. Adolescents’ attitudes about HIV immunization. J Pediatr Psychol. 1999;24(1):67–75
  15. Zimet GD, Blythe MJ, Fortenberry JD. Vaccine characteristics and acceptability of HIV immunization among adolescents. Int J STD AIDS. 2000;11(3):143–149
  16. Levy PS, Lemeshow S. Sampling of Populations: Methods and Applications. 3rd ed.. New York, NY: Wiley-Interscience; 1999;
  17. Buchbinder SP, Metch B, Holte SE, et al. Determinants of enrollment in a preventive HIV vaccine trial. J Acquir Immune Defic Syndr. 2004;36:604–612
  18. Luke N. Confronting the ’sugar daddy’ stereotype: age and economic asymmetries and risky sexual behavior in urban Kenya. Int Fam Plann Persp. 2005;31(1):6–14
  19. Markham CM, Fleschler M, Addy AC, et al. Vaginal, oral and anal sex behaviors among middle school youth. American Public Health Association 133rd Annual Meeting & Exposition. Philadelphia, PA: December 10–14, 2005.
  20. Halpern-Felsher BL, Cornell JL, Kropp RY, et al. Oral versus vaginal sex among adolescents: perceptions, attitudes, and behavior. Pediatrics. 2005;115(4):845–851
  21. Magnani RJ, Karim AM, Weiss LA, et al. Reproductive health risk and protective factors among youth in Lusaka, Zambia. J Adolesc Health. 2002;30(1):76–86
  22. Roche KM, Ellen J, Astone NM. Effects of out-of-school care on sex initiation among young adolescents in low-income central city neighborhoods. Arch Pediatr Adolesc Med. 2005;159(1):68–73
  23. Flisher AJ, Townsend L, Chikobvu P, et al. Sexual behaviour and high-school dropout in South Africa. 52nd Annual Meeting of the American Academy of Child and Adolescent Psychiatry and 25th Annual Meeting of the Canadian Association of Child and Adolescent Psychiatry, Toronto, Canada, 18–23 October 2005.
  24. Golub ET, Purvis LA, Sapun M, et al. Changes in willingness to participate in HIV vaccine trials among HIV-negative injection drug users. Breast Cancer Res Treat. 2005;94(2):301–309
  25. Kiwanuka N, Robb M, Kigozi G, et al. Knowledge about vaccines and willingness to participate in preventive HIV vaccine trials: a population-based study, Rakai, Uganda. J Acquir Immune Defic Syndr. 2004;36(2):721–725
  26. Jenkins RA, Torugsa K, Markowitz LE, et al. Willingness to participate in HIV-1 vaccine trials among young Thai men. Sex Transm Infect. 2000;76(5):386–392
  27. O’Connell JM, Hogg RS, Chan K, et al. Willingness to participate and enroll in a phase 3 preventive HIV-1 vaccine trial. J Acquir Immune Defic Syndr. 2002;31(5):521–528
  28. Orner P, Harries J, Cooper D, et al. Challenges to microbicide introduction in South Africa. Soc Sci Med. 2006;Apr 4 [E pub]
  29. Zimet G, Fortenberry D, Blythe M, et al. Health beliefs and vaccine characteristics predict HIV vaccine acceptance among adolescent patients. J Adolesc Health. 1996;18:148

PII: S1054-139X(06)00196-0

doi: 10.1016/j.jadohealth.2006.05.016

Journal of Adolescent Health
Volume 39, Issue 5 , Pages 642-648 , November 2006

Article Tools